Medical News

RSS

Oramed Pharmaceuticals completes Phase 2b study of ORMD-0801 oral insulin capsule

Oramed Pharmaceuticals Inc. announced today the completion of its' pivotal Phase 2b clinical study of its oral insulin capsule, ORMD-0801. The Company expects to report results from this study within the coming weeks.

26 Mar 2010

Targeting Wnt/beta-catenin pathway may prevent growth and development of AML: Study

About 40 percent of children and up to 70 percent of adults in remission from acute myelogenous leukemia will have a relapse. In recent years, doctors have come to believe that this is due to leukemia stem cells, endlessly replicating cancer cells that generate the immature blood cells characteristic of leukemia and are resistant to typical cancer treatments.

26 Mar 2010

Lay health workers can help reduce childhood mortality

Lay persons in many countries who are given special training to promote or carry out some health care services may reduce childhood mortality.

26 Mar 2010

World TB Day coverage: Lesotho, Armenia, drug resistance, HIV coinfection

"To mark World [Tuberculosis] Day on Wednesday, Medecins Sans Frontieres [MSF] drew attention to Lesotho, which has the world's third-highest prevalence of HIV ... and the fourth-highest prevalence of tuberculosis," the Associated Press reports

26 Mar 2010

Short-term economic boom not always good for children in developing nations

A short-term economic boom is not always a good thing for children in developing nations, according to a new study in the Journal of Political Economy. The study found that when Colombia's coffee trade suddenly booms, illness and mortality rates among children increase in coffee-producing counties.

26 Mar 2010

States challenge health insurance coverage mandate as leaders decide on participation

Attorneys general in 14 states have filed lawsuits challenging the constitutionality of a health insurance coverage mandate in the new federal health law, and more may follow.

26 Mar 2010

ONA President’s statement on Ontario provincial budget

Ontario Nurses' Association (ONA) President Linda Haslam-Stroud, RN says that today's provincial budget means more service and nursing cuts for patients in this province.

26 Mar 2010

RXi Pharmaceuticals obtains commitments to purchase 2.7M shares of common stock at $6.00 per share

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference, announced today that it has obtained commitments from several investors to purchase 2.7 million shares of its common stock at $6.00 per share and warrants to purchase 540,000 shares of its common stock for gross proceeds of $16.2 million.

26 Mar 2010

Parties vie for political momentum after health vote

The health care debate has already become a proxy for 2010 election fights, with candidates in both parties wielding the issue, according to The Wall Street Journal: "In Kentucky, the two leading Democrats seeking an open Senate seat are battling over who has been most committed to the health-care law." Meanwhile, "[two] potential 2012 presidential candidates, Republicans Sarah Palin and Mitt Romney, both issued fund-raising appeals to their supporters, saying they would use the money to fight for the GOP position on the health-care law" (Wallsten, 3/25).

26 Mar 2010

FDA grants tentative approval for Teva Pharmaceutical Industries' generic Argatroban ANDA

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) to market a generic version of the anticoagulant, Argatroban® injection, 100mg/mL.

26 Mar 2010

Early screening for diabetes and kidney disease can improve health outcomes

Millions of Americans may have chronic kidney disease (CKD) and not know it, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).

26 Mar 2010

New report urges government to ban smoking in cars to limit children's exposure to passive smoke

A new report released by the Tobacco Advisory Group of the Royal College of Physicians urges the government to ban smoking in cars and other public vehicles to limit children's exposure to passive smoke.

26 Mar 2010

SMA Foundation completes biomarker study for Spinal Muscular Atrophy

The Spinal Muscular Atrophy (SMA) Foundation, a nonprofit organization dedicated to accelerating the development of a treatment for SMA, is pleased to announce the completion of a pilot study to identify Biomarkers for Spinal Muscular Atrophy (BforSMA) and the discovery of over 400 candidate biomarkers.

26 Mar 2010

Interim results from ZALBIN Phase 2B trial in chronic hepatitis C patients announced

Human Genome Sciences, Inc. today announced interim results through Week 12 following the end of treatment in a Phase 2b clinical trial conducted by Novartis to evaluate the safety and efficacy of ZALBIN™ (albinterferon alfa-2b), an investigational agent, administered monthly in combination with ribavirin in 391 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C virus. The primary efficacy endpoint is sustained virologic response (SVR) at Week 48 (24 weeks following the end of treatment).

26 Mar 2010

Artist and scientist examine principles of visual perception

A novel research project spearheaded by the University of Leicester and part-funded by The Leverhulme Trust aims to shed new light on the way people perceive art.

26 Mar 2010

New PreXion3D Volumetric Imaging Software for 3D CBCT system launched

PreXion, Inc., the leader in high quality 3D Cone Beam Imaging systems for dentistry, today announced that it has launched and started shipping new PreXion3D Volumetric Imaging Software for its 3D Cone Beam Computed Tomography system for dentistry. This new product incorporates a range of advanced features including tools for implant planning and placement and an enhanced version of its PrexViewer software.

26 Mar 2010

Renowned experts discuss key statistics of health care reform at 2010 Keenan Summit

Keenan & Associates, the largest privately-held insurance brokerage and consulting firm in California, convened its sixth annual Keenan Summit on March 3, 2010, in Pasadena, Calif., and on March 4, 2010, in Berkeley. The theme for this year's summit was "Navigating Through Unprecedented Times: Today's Challenges. Tomorrow's Solutions."

26 Mar 2010

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration has approved once-daily Mirapex ER® (pramipexole dihydrochloride) extended-release tablets for the signs and symptoms of idiopathic Parkinson's disease, which includes early and advanced PD. PD is the second most common chronic neurological disorder in older adults after Alzheimer's. Parkinson's disease has no cure.

26 Mar 2010

Overhaul will affect other economic sectors, not just health care

Health-overhaul legislation signed into law this week will affect not only America's health care industry, but the broader economy, too, The Christian Science Monitor reports. The overhaul could help create jobs. "But the legislation also means tax hikes, mainly on the highest-income Americans. And provisions designed to curb healthcare costs probably aren't strong enough to put a big dent in medical inflation - or federal budget deficits" (Trumbull, 3/24).

26 Mar 2010

Dyax to use proceeds of public offering for commercialization and distribution activities of KALBITOR

Dyax Corp. today announced the pricing of an underwritten public offering of 17,000,000 shares of its common stock at a price to the public of $3.25 per share. The gross proceeds from the sale of shares, after underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $51.8 million. The offering is expected to close on or about March 30, 2010, subject to customary closing conditions.

26 Mar 2010

Medical News

Oramed Pharmaceuticals completes Phase 2b study of ORMD-0801 oral insulin capsule

Targeting Wnt/beta-catenin pathway may prevent growth and development of AML: Study

Lay health workers can help reduce childhood mortality

World TB Day coverage: Lesotho, Armenia, drug resistance, HIV coinfection

Short-term economic boom not always good for children in developing nations

States challenge health insurance coverage mandate as leaders decide on participation

ONA President’s statement on Ontario provincial budget

RXi Pharmaceuticals obtains commitments to purchase 2.7M shares of common stock at $6.00 per share

Parties vie for political momentum after health vote

FDA grants tentative approval for Teva Pharmaceutical Industries' generic Argatroban ANDA

Early screening for diabetes and kidney disease can improve health outcomes

New report urges government to ban smoking in cars to limit children's exposure to passive smoke

SMA Foundation completes biomarker study for Spinal Muscular Atrophy

Interim results from ZALBIN Phase 2B trial in chronic hepatitis C patients announced

Artist and scientist examine principles of visual perception

New PreXion3D Volumetric Imaging Software for 3D CBCT system launched

Renowned experts discuss key statistics of health care reform at 2010 Keenan Summit

FDA approves Mirapex ER tablets for signs and symptoms of idiopathic PD

Overhaul will affect other economic sectors, not just health care

Dyax to use proceeds of public offering for commercialization and distribution activities of KALBITOR

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News